Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information
This activity will review the latest PK recommendations for Factor VIII and IX replacement and how to use and interpret PK parameters to assess treatment plans.
Choose from the criteria below to find an activity that fits you best.
NOTE: If you attended this CE activity live (via webinar) on May 2, 2019, AND received CE credit (i.e. a pharmacist CE statement with ACPE Universal Activity Number 0221-9999-19-157-L01-P, or Laboratory PACE credit), you are NOT allowed to also receive CE credit for this home-study activity.
Join us for this annual webcast that provides updates on hot topics related to antibiotic stewardship and microbiological testing. This year’s webcast will include recent CLSI antimicrobial susceptibility testing updates for gram positive and gram negative bacteria. We will also discuss ways to incorporate these changes in your antimicrobial stewardship efforts.
James S. Lewis II, Pharm.D., FIDSA
Infectious Diseases Pharmacy Clinical Coordinator
Oregon Health and Science University
Kristi Traugott, PharmD, BCPS, BCIDP
Clinical Pharmacy Specialist, Infectious Disease
PGY2 Infectious Diseases Pharmacy Residency Program Director
University Health System
Department of Pharmacotherapy and Pharmacy Services
UTHSCSA - PERC
San Antonio, Texas
Release Date: May 2, 2019
Expiration Date: May 2, 2020
This CE activity is jointly provided by ProCE, Inc., CLSI, and SIDP. ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-19-157-H01-P has been assigned to this knowledge-based home study CE activity (initial release date 5-2-19). This CE activity is approved for 1.0 contact hour (0.1 CEU) in states that recognize ACPE providers. Successful completion of an online post-test and evaluation at www.ProCE.com is required to receive CE credit. No partial credit will be given.
Clinical and Laboratory Standards Institute is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.â Program. To receive Laboratory PACE credit, please fill out this form on the CLSI website and your certificate will be e-mailed to you upon completion: https://clsi.org/global-training/earn-ce-credits/pace-ce-credits-merging-microbiology-and-stewardship/
It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and
scientific rigor in all of its continuing education activities. Faculty must disclose
to participants any significant financial interest or affiliation with companies that
manufacture or market products discussed in this activity. Dr. Traugott has no relevant
commercial and/or financial relationships to disclose. Dr. Lewis has served as an
Advisory Board member for Merck and a Consultant for Tetraphase.
Please note: The information and views presented in this activity are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include the use of drugs and/or devices for unlabeled indications, which should be considered experimental. Participants are advised to consult manufacturer product information and the professional literature, and use professional judgment in applying the presented information in patient-care activities.
This activity is self-funded by SIDP, CLSI, and members of ACCP ID PRN.
The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.